Original Communication| Volume 147, ISSUE 3, P352-357, March 2010

Predictors of occult nodal metastasis in colon cancer: Results from a prospective multicenter trial

Published:February 01, 2010DOI:


      The relationship between primary colon cancer and occult nodal metastases (OMs) detected by cytokeratin immunohistochemistry (CK-IHC) is unknown. We sought to investigate the correlation of clinicopathologic features of colon cancer with OMs and to identify predictors of OM.


      Patients with colon cancer from 5 tertiary referral cancer centers enrolled in a prospective trial of staging had standard pathologic analysis performed on all resected lymph nodes (using hematoxylin and eosin staining [H&E]). Nodes negative on H&E underwent CK-IHC to detect OMs, which were defined as micrometastases (N1mic) or isolated tumor cells (N0i+). Patients who were negative on both H&E and CK-IHC were defined as node negative (NN), and those positive on H&E were node positive (NP). The relationships between tumor characteristics and OMs were analyzed using the Kruskal-Wallis and the Fisher exact test.


      OMs were identified in 23.4% (25/107) of patients. No significant differences were found in demographics, tumor location, tumor size, and number of nodes examined between groups. Compared with the NN group, patients with OMs had more tumors that were T3/T4 (72% vs 57%; P < .001), had tumors of higher grade (28% vs 12%; P = .022), and had tumors with lymphovascular invasion (16% vs 3%; P < .001).


      Adverse primary pathologic colon cancer characteristics correlate with OMs. In patients with negative nodes on H&E and stage T3/T4 colon cancer, lymphovascular invasion, or high tumor grade, consideration should be given to performing CK-IHC. The detection of OMs in this subset may influence decisions regarding adjuvant chemotherapy and risk stratification.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cohen A.M.
        • Kelsen D.
        • Saltz L.
        • Minsky B.D.
        • Nelson H.
        • Farouk R.
        • et al.
        Adjuvant therapy for colorectal cancer.
        Curr Probl Surg. 1997; 34: 601-676
        • Adell G.
        • Boeryd B.
        • Franlund B.
        • Sjodahl R.
        • Hakansson L.
        Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study.
        Eur J Surg. 1996; 162: 637-642
        • Sasaki M.
        • Watanabe H.
        • Jass J.R.
        • Ajioka Y.
        • Kobayashi M.
        • Matsuda K.
        • et al.
        Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in “node-negative” colorectal cancer.
        J Gastroenterol. 1997; 32 (78–64)
        • Noura S.
        • Yamamoto H.
        • Miyake Y.
        • Kim B.
        • Takayama O.
        • Seshimo I.
        • et al.
        Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer.
        Clin Cancer Res. 2002; 8: 759-767
        • Noura S.
        • Hirofumi Y.
        • Ohnishi T.
        • Masuda N.
        • Matsumoto T.
        • Takayama O.
        • et al.
        Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry.
        J Clin Oncol. 2002; 20: 4232-4241
        • Palma R.T.
        • Waisberg J.
        • Bromberg S.H.
        • Simao A.B.
        • Godoy A.C.
        Micrometastasis in regional lymph nodes of extirpated colorectal carcinoma: immunohistochemical study using anti-cytokeratin antibodies AE1/AE3.
        Colorectal Dis. 2003; 5: 164-168
        • Green F.L.
        • Page D.L.
        • Fleming I.D.
        Cancer staging manual.
        6th ed. Springer Verlag, New York2002
        • Sobin L.H.
        • Wittekind C.
        TNM classification of malignant tumors.
        6th ed. Wiley, New York2002
        • Bilchik A.J.
        • Hoon D.S.
        • Saha S.
        • Turner R.R.
        • Wiese D.
        • DiNome M.
        • et al.
        Prognostic impact of micrometastsaes in colon cancer: interim results of a prospective multicenter trial.
        Ann Surg. 2007; 246: 568-575
        • Bilchik A.J.
        • DiNome M.
        • Saha S.
        • Turner R.
        • Wiese D.
        • McCarter M.
        • et al.
        Prospective multicenter trial of staging adequacy in colon cancer.
        Arch Surg. 2006; 141: 527-534
        • Mescoli C.
        • Rugge M.
        • Pucciarelli S.
        • Russo V.M.
        • Pennelli G.
        • Guido M.
        • et al.
        High prevalence of isolated tumor cells in regional lymph nodes from pN0 colorectal cancer.
        J Clin Pathol. 2006; 59: 870-874
        • Okabe S.
        • Shia J.
        • Nash G.
        • Wong W.D.
        • Guillem J.G.
        • Weiser M.R.
        • et al.
        Lymph node metastasis in T1 adenocarcinoma of the colon and rectum.
        J Gastrointest Surg. 2004; 8: 1039-1040
        • Nascimbeni R.
        • Burgart L.J.
        • Nivatvongs S.
        • Larson D.R.
        Risk of lymph node metastasis in T1 carcinoma of the colon and rectum.
        Dis Colon Rectum. 2002; 45: 200-206
        • Chok K.S.
        • Law W.L.
        Prognostic dactors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer.
        World J Surg. 2007; 31: 1485-1490
        • Burdy G.
        • Panis Y.
        • Alves A.
        • Nemeth J.
        • Lavergne-Slove A.
        • Valleur P.
        • et al.
        Identifying patients with T3-T4 node negative colon cancer at high risk for recurrence.
        Dis Colon Rectum. 2001; 44: 1682-1688
        • Weiser M.R.
        • Landmann R.G.
        • Kattan M.W.
        • Gonen M.
        • Shia J.
        • Chou J.
        • et al.
        Individualized prediction of colon cancer recurrence using a normogram.
        J Clin Oncol. 2008; 26: 380-385
        • Compton C.
        • Fenoglio-Preiser C.M.
        • Pettigrew N.
        • Fielding L.P.
        American Joint Committee on cancer prognostic factors consensus conference: Colorectal Working Group.
        Cancer. 2000; 88: 1739-1757
        • Benson 3rd, A.B.
        • Schrag D.
        • Somerfield M.R.
        • Cohen A.M.
        • Figueredo A.T.
        • Flynn P.J.
        • et al.
        American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
        J Clin Oncol. 2004; 22: 3408-3419
        • André T.
        • Sargent D.
        • Tabernero J.
        • O'Connell M.
        • Buyse M.
        • Sobrero A.
        • et al.
        Current issues in adjuvant treatment of Stage II colon cancer.
        Ann Surg Oncol. 2006; 13: 887-898
        • Yasuda K.
        • Adachi Y.
        • Shiraishi N.
        • Yamaguchi K.
        • Hirabayashi Y.
        • Kitano S.
        • et al.
        Pattern of lymph node micrometastases and prognosis of patients with colorectal cancer.
        Ann Surg Oncol. 2001; 8: 300-304
        • Tschmelitsch J.
        • Klimstra D.S.
        • Cohen A.M.
        Lymph node micrometastases do not predict relapse in stage II colon cancer.
        Ann Surg Oncol. 2000; 7: 601-608
        • Stojadinovic A.
        • Nissan A.
        • Protic M.
        • Adair C.F.
        • Prus D.
        • Usaj S.
        • et al.
        Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study G1-01.
        Ann Surg. 2007; 245: 846-857
        • Bembenek A.E.
        • Rosenberg R.
        • Wagler E.
        • Gretschel S.
        • Sendler A.
        • Siewert J.R.
        • et al.
        Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial.
        Ann Surg. 2007; 245: 864-866